Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2009

01-09-2009 | Article

Detection of Salmonella enterica serovar Typhimurium with pUO-StVR2-like virulence-resistance hybrid plasmids in the United Kingdom

Authors: A. Herrero, M. C. Mendoza, E. J. Threlfall, M. R. Rodicio

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2009

Login to get access

Abstract

The aim of this study was to investigate the presence in the United Kingdom (UK) of Salmonella enterica serovar Typhimurium isolates carrying pUO-StVR2-like virulence-resistance hybrid plasmids that originated from pSLT. One hundred and fifty ampicillin-resistant isolates of S. Typhimurium, collected in different regions of the UK during 2006, were screened for the presence of bla OXA-1 carried by an InH-like integron (2000 bp/bla OXA-1-aadA1) characteristic of pUO-StVR2. Positive isolates were tested for the presence of a large plasmid that hybridised with probes specific for the bla OXA-1 and spvC genes, used as resistance and virulence markers of the hybrid plasmid, respectively. Eleven out of the 150 isolates fulfilled both criteria and were assigned to the S. Typhimurium pUO-StVR2 group. Nine were resistant to ampicillin, chloramphenicol, streptomycin/spectinomycin, sulfonamides and tetracycline, encoded by bla OXA-1, catA1, aadA1-like, sul1 and tet(B), respectively, and carried a pUO-StVR2-like plasmid of ca. 130 kb. Two contained hybrid plasmids of smaller size and lacked resistance(s) to chloramphenicol or chloramphenicol and tetracycline. The eleven isolates, which showed five and six closely related XbaI and BlnI profiles, respectively, were resistant to nitrofurantoin. In conclusion, multidrug-resistant S. Typhimurium isolates of the pUO-StVR2 group, which are endemic in Spain, were also detected in the UK, albeit with a low frequency (7.3%).
Literature
1.
go back to reference Guerra B, Soto S, Helmuth R et al (2002) Characterization of a self-transferable plasmid from Salmonella enterica serotype Typhimurium clinical isolates carrying two integron-borne gene cassettes together with virulence and drug resistance genes. Antimicrob Agents Chemother 46:2977–2981. doi:10.1128/AAC.46.9.2977-2981.2002 PubMedCrossRef Guerra B, Soto S, Helmuth R et al (2002) Characterization of a self-transferable plasmid from Salmonella enterica serotype Typhimurium clinical isolates carrying two integron-borne gene cassettes together with virulence and drug resistance genes. Antimicrob Agents Chemother 46:2977–2981. doi:10.​1128/​AAC.​46.​9.​2977-2981.​2002 PubMedCrossRef
2.
go back to reference Herrero A, Rodicio MR, González-Hevia MA et al (2006) Molecular epidemiology of emergent multidrug-resistant Salmonella enterica serotype Typhimurium strains carrying the virulence resistance plasmid pUO-StVR2. J Antimicrob Chemother 57:39–45. doi:10.1093/jac/dki400 PubMedCrossRef Herrero A, Rodicio MR, González-Hevia MA et al (2006) Molecular epidemiology of emergent multidrug-resistant Salmonella enterica serotype Typhimurium strains carrying the virulence resistance plasmid pUO-StVR2. J Antimicrob Chemother 57:39–45. doi:10.​1093/​jac/​dki400 PubMedCrossRef
4.
5.
go back to reference Antunes P, Machado J, Sousa JC et al (2004) Dissemination amongst humans and food products of animal origin of a Salmonella typhimurium clone expressing an integron-borne OXA-30 β-lactamase. J Antimicrob Chemother 54:429–434. doi:10.1093/jac/dkh333 PubMedCrossRef Antunes P, Machado J, Sousa JC et al (2004) Dissemination amongst humans and food products of animal origin of a Salmonella typhimurium clone expressing an integron-borne OXA-30 β-lactamase. J Antimicrob Chemother 54:429–434. doi:10.​1093/​jac/​dkh333 PubMedCrossRef
6.
go back to reference Lindstedt B-A, Heir E, Nygård I et al (2003) Characterization of class I integrons in clinical strains of Salmonella enterica subsp. enterica serovars Typhimurium and Enteritidis from Norwegian hospitals. J Med Microbiol 52:141–149. doi:10.1099/jmm.0.04958-0 PubMedCrossRef Lindstedt B-A, Heir E, Nygård I et al (2003) Characterization of class I integrons in clinical strains of Salmonella enterica subsp. enterica serovars Typhimurium and Enteritidis from Norwegian hospitals. J Med Microbiol 52:141–149. doi:10.​1099/​jmm.​0.​04958-0 PubMedCrossRef
7.
go back to reference Helms M, Ethelberg S, Mølbak K; DT104 Study Group (2005) International Salmonella Typhimurium DT104 infections, 1992–2001. Emerg Infect Dis 11:859–867PubMed Helms M, Ethelberg S, Mølbak K; DT104 Study Group (2005) International Salmonella Typhimurium DT104 infections, 1992–2001. Emerg Infect Dis 11:859–867PubMed
10.
go back to reference Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing—15th informational supplement. Approved standard M100–S15. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing—15th informational supplement. Approved standard M100–S15. CLSI, Wayne, PA
12.
go back to reference Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680. doi:10.1093/nar/22.22.4673 PubMedCrossRef Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680. doi:10.​1093/​nar/​22.​22.​4673 PubMedCrossRef
13.
go back to reference Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145:1365–1373PubMed Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145:1365–1373PubMed
14.
go back to reference Peters TM, Maguire C, Threlfall EJ et al (2003) The Salm-gene project: a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill 8:46–50PubMed Peters TM, Maguire C, Threlfall EJ et al (2003) The Salm-gene project: a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill 8:46–50PubMed
15.
go back to reference Liu S-L, Hessel A, Sanderson KE (1993) The XbaI-BlnI-CeuI genomic cleavage map of Salmonella typhimurium LT2 determined by double digestion, end labelling, and pulsed-field gel electrophoresis. J Bacteriol 175:4104–4120PubMed Liu S-L, Hessel A, Sanderson KE (1993) The XbaI-BlnI-CeuI genomic cleavage map of Salmonella typhimurium LT2 determined by double digestion, end labelling, and pulsed-field gel electrophoresis. J Bacteriol 175:4104–4120PubMed
16.
go back to reference Lawson AJ, Dassama MU, Ward LR et al (2002) Multiply resistant (MR) Salmonella enterica serotype Typhimurium DT 12 and DT 120: a case of MR DT 104 in disguise? Emerg Infect Dis 8:434–436PubMed Lawson AJ, Dassama MU, Ward LR et al (2002) Multiply resistant (MR) Salmonella enterica serotype Typhimurium DT 12 and DT 120: a case of MR DT 104 in disguise? Emerg Infect Dis 8:434–436PubMed
17.
go back to reference Council Regulation (EEC) No. 2901/93 of 18 October 1993 amending Annexes I, II, III and IV to Regulation (EEC) No. 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal L 264:1–4 Council Regulation (EEC) No. 2901/93 of 18 October 1993 amending Annexes I, II, III and IV to Regulation (EEC) No. 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal L 264:1–4
18.
go back to reference Council Regulation (EEC) No. 1442/95 of 26 June 1995 on amending Annexes I, II, III and IV of Council Regulation (EEC) No. 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal L 143:26–30 Council Regulation (EEC) No. 1442/95 of 26 June 1995 on amending Annexes I, II, III and IV of Council Regulation (EEC) No. 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal L 143:26–30
20.
go back to reference Antunes P, Machado J, Peixe L (2006) Illegal use of nitrofurans in food animals: contribution to human salmonellosis? Clin Microbiol Infect 12:1047–1049PubMedCrossRef Antunes P, Machado J, Peixe L (2006) Illegal use of nitrofurans in food animals: contribution to human salmonellosis? Clin Microbiol Infect 12:1047–1049PubMedCrossRef
22.
go back to reference Threlfall EJ, Day M, de Pinna E et al (2006) Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004. Int J Antimicrob Agents 28:389–395. doi:10.1016/j.ijantimicag.2006.07.009 PubMedCrossRef Threlfall EJ, Day M, de Pinna E et al (2006) Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004. Int J Antimicrob Agents 28:389–395. doi:10.​1016/​j.​ijantimicag.​2006.​07.​009 PubMedCrossRef
23.
go back to reference Meakins S, Fisher IST, Berghold C et al (2008) Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist 14:31–35. doi:10.1089/mdr.2008.0777 PubMedCrossRef Meakins S, Fisher IST, Berghold C et al (2008) Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000–2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist 14:31–35. doi:10.​1089/​mdr.​2008.​0777 PubMedCrossRef
24.
go back to reference European Union Council Directive 2003/99/EC of the European Parliament and of the Council of 17th of November 2003 on the monitoring of zoonoses and zoonotic agents amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. Official Journal L 325:31–40 European Union Council Directive 2003/99/EC of the European Parliament and of the Council of 17th of November 2003 on the monitoring of zoonoses and zoonotic agents amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. Official Journal L 325:31–40
25.
go back to reference European Union Regulation No. 2160/2003 on the control of salmonella and other specified food-borne zoonotic agents. Official Journal L 325:1–15 European Union Regulation No. 2160/2003 on the control of salmonella and other specified food-borne zoonotic agents. Official Journal L 325:1–15
26.
go back to reference Bronzwaer S, Lönnroth A, Haigh R (2004) The European Community strategy against antimicrobial resistance. Euro Surveill 9:30–34PubMed Bronzwaer S, Lönnroth A, Haigh R (2004) The European Community strategy against antimicrobial resistance. Euro Surveill 9:30–34PubMed
Metadata
Title
Detection of Salmonella enterica serovar Typhimurium with pUO-StVR2-like virulence-resistance hybrid plasmids in the United Kingdom
Authors
A. Herrero
M. C. Mendoza
E. J. Threlfall
M. R. Rodicio
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0753-1

Other articles of this Issue 9/2009

European Journal of Clinical Microbiology & Infectious Diseases 9/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.